LY03017 is named as a drug or biological intervention in 2 clinical trials in our China trial register, none of which are currently recruiting. The lead sponsor is Luye Pharma Group Ltd.. Registered phase: Phase 1. Conditions studied include Negative Symptoms of Schizophrenia; Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis; Hallucinations and Delusions Associated With Parkinson Disease Psychosis.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06793995 | Effect of Food and Age on the Pharmacokinetics of LY03017 (ClinicalTrials.gov ↗) Alzheimer's Disease Psychosis, Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia |
Phase 1 | Not yet open |
| NCT06980207 | A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 (ClinicalTrials.gov ↗) Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia |
Phase 1 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Negative Symptoms of Schizophrenia | 2 |
| Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis | 1 |
| Hallucinations and Delusions Associated With Parkinson Disease Psychosis | 1 |
| Alzheimer's Disease Psychosis | 1 |
| Parkinson Disease Psychosis | 1 |
| Lead sponsor | Trials |
|---|---|
| Luye Pharma Group Ltd. | 2 |
| Register | LY03017 trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how LY03017 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists LY03017 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.